231 related articles for article (PubMed ID: 9916343)
1. [Constitutional thrombopathies: from the clinical description of rare diseases (Glanzmann thrombasthenia and Bernard-Soulier syndrome) to the development of new antithrombotic agents].
Caen J; Bellucci S
Bull Acad Natl Med; 1998; 182(7):1493-502; discussion 1502-3. PubMed ID: 9916343
[TBL] [Abstract][Full Text] [Related]
2. Molecular abnormalities in Glanzmann's thrombasthenia, Bernard-Soulier syndrome, and platelet-type von Willebrand's disease.
Clemetson KJ; Clemetson JM
Curr Opin Hematol; 1994 Sep; 1(5):388-93. PubMed ID: 9371310
[TBL] [Abstract][Full Text] [Related]
3. Platelet-vessel wall interaction: from the bedside to molecules.
Caen JP; Rosa JP
Thromb Haemost; 1995 Jul; 74(1):18-24. PubMed ID: 8578453
[TBL] [Abstract][Full Text] [Related]
4. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
5. Both the high affinity thrombin receptor (GPIb-IX-V) and GPIIb/IIIa are implicated in expression of thrombin-induced platelet procoagulant activity.
Dicker IB; Pedicord DL; Seiffert DA; Jamieson GA; Greco NJ
Thromb Haemost; 2001 Oct; 86(4):1065-9. PubMed ID: 11686325
[TBL] [Abstract][Full Text] [Related]
6. Glanzmann's thrombasthenia: updated.
Nair S; Ghosh K; Kulkarni B; Shetty S; Mohanty D
Platelets; 2002 Nov; 13(7):387-93. PubMed ID: 12487785
[TBL] [Abstract][Full Text] [Related]
7. The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium.
Sakariassen KS; Nievelstein PF; Coller BS; Sixma JJ
Br J Haematol; 1986 Aug; 63(4):681-91. PubMed ID: 2942171
[TBL] [Abstract][Full Text] [Related]
8. [Membrane glycoproteins of human platelets: structures, functions, and abnormalities in Glanzmann's thrombasthenia and Bernard-Soulier syndrome].
Ando Y; Fusegawa H; Kawada T; Tanaka Y; Watanabe K; Kobayashi N
Rinsho Byori; 1989 Dec; 37(12):1344-52. PubMed ID: 2614964
[TBL] [Abstract][Full Text] [Related]
9. Platelet adhesion to fibrin(ogen).
Endenburg SC; Hantgan RR; Sixma JJ; de Groot PG; Zwaginga JJ
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):139-42. PubMed ID: 8457642
[TBL] [Abstract][Full Text] [Related]
10. [The immunodiagnosis of thrombocyte membrane glycoprotein deficiencies: Glanzmann's thrombasthenia, Bernard-Soulier syndrome and GMP-140 protein deficiency].
Agafonova OG; Vinogradov DV; Khaspekova SG; Lagutina NIa; Labinskaia TA; Vasil'ev SA; Mazurov AV
Biull Eksp Biol Med; 1992 Dec; 114(12):635-7. PubMed ID: 1284039
[TBL] [Abstract][Full Text] [Related]
11. Molecular defects in the Bernard-Soulier syndrome: assessment of receptor genes, transcripts and proteins.
Roth GJ
C R Acad Sci III; 1996 Sep; 319(9):819-26. PubMed ID: 8952885
[TBL] [Abstract][Full Text] [Related]
12. Bernard-Soulier syndrome with severe bleeding: absent platelet glycoprotein Ib alpha due to a homozygous one-base deletion.
Li C; Pasquale DN; Roth GJ
Thromb Haemost; 1996 Nov; 76(5):670-4. PubMed ID: 8950770
[TBL] [Abstract][Full Text] [Related]
13. Inherited diseases of platelet glycoproteins: considerations for rapid molecular characterization.
Bray PF
Thromb Haemost; 1994 Oct; 72(4):492-502. PubMed ID: 7878622
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and molecular basis of Glanzmann's thrombasthenia.
Perutelli P; Mori PG
Haematologica; 1992; 77(5):421-6. PubMed ID: 1483593
[TBL] [Abstract][Full Text] [Related]
15. Role of the leucine-rich domain of platelet GPIbalpha in correct post-translational processing--the Nancy I Bernard-Soulier mutation expressed on CHO cells.
Ulsemer P; Lanza F; Baas MJ; Schwartz A; Ravanat C; Briquel ME; Cranmer S; Jackson S; Cazenave JP; de la Salle C
Thromb Haemost; 2000 Jul; 84(1):104-11. PubMed ID: 10928479
[TBL] [Abstract][Full Text] [Related]
16. Are patients with Glanzmann thrombasthenia and the Bernard-Soulier syndrome protected against atherosclerosis?
Nurden AT; Nurden P; George JN
Adv Exp Med Biol; 2001; 489():13-29. PubMed ID: 11554587
[No Abstract] [Full Text] [Related]
17. Platelet function tests using platelet aggregometry: need for repetition of the test for diagnosis of defective platelet function.
Ghosh K; Nair S; Kulkarni B; Khare A; Shetty S; Mohanty D
Platelets; 2003 Sep; 14(6):351-4. PubMed ID: 14602548
[TBL] [Abstract][Full Text] [Related]
18. [Platelet aggregations and glycoproteins].
Yamamoto N; Arai M; Tanoue K
Rinsho Byori; 1992 Mar; 40(3):272-81. PubMed ID: 1518178
[TBL] [Abstract][Full Text] [Related]
19. Decreased thrombotic tendency in mouse models of the Bernard-Soulier syndrome.
Strassel C; Nonne C; Eckly A; David T; Leon C; Freund M; Cazenave JP; Gachet C; Lanza F
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):241-7. PubMed ID: 17095718
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of the Bernard-Soulier syndrome, platelet-type von Willebrand's disease and Glanzmann's thrombasthenia.
Clemetson KJ; Clemetson JM
Beitr Infusionsther; 1993; 31():168-73. PubMed ID: 7693249
[No Abstract] [Full Text] [Related]
[Next] [New Search]
